Related Experiment Video
Updated: Jun 18, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Stents and drug-eluting stents
Karen A Bednarski1, Frederick A Kuhn
1Georgia Nasal and Sinus Institute, 4750 Waters Avenue, Suite 112, Savannah, GA 31404, USA.
This review examines endoscopic sinus surgery complications, specifically synechiae and ostial stenosis. It evaluates the benefits and drawbacks of surgical stents, including novel drug-releasing options, to prevent these issues.
Area of Science:
- Otolaryngology
- Surgical Innovation
Background:
- Synechiae and ostial stenosis are frequent complications after endoscopic sinus surgery (ESS).
- These complications can significantly impact patient outcomes and quality of life.
- Current management strategies include surgical intervention and the use of implants.
Purpose of the Study:
- To review the advantages and disadvantages of various stents used in sinus surgery.
- To discuss the efficacy of stents in preventing postoperative synechiae and ostial stenosis.
- To explore innovative stent technologies, such as drug-releasing stents.
Main Methods:
- Literature review of studies on sinus surgery complications and stent use.
- Analysis of clinical evidence regarding the effectiveness of different stent types.
- Discussion of emerging technologies in sinonasal implants.
Main Results:
- Evidence on the benefit of traditional stents for preventing stenosis is mixed.
- Drug-releasing stents represent a promising innovation for managing inflammation and preventing adhesions.
- Stent selection should be individualized based on surgical complexity and patient factors.
Conclusions:
- Stent use in ESS remains a topic of debate with varying clinical outcomes.
- Drug-eluting stents offer potential advantages in reducing complications and improving healing.
- Further research is needed to establish optimal stent selection and long-term efficacy.
Related Concept Videos
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Intrauterine Drug Delivery Systems
Angina IV: Management
